🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

An Italian Multicentric Retrospective Observational Study to Assess Effectiveness and Safety of the Combination of Tafasitamab and Lenalidomide in Diffuse Large B-cell Lymphoma Patients Treated Under Named Patient Program

Recruitingn/aAges 18 Years - anyAllIRCCS Azienda Ospedaliero-Universitaria di Bologna
NCT06782789 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study is pilot, observational, retrospective, Italian multicenter study.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Histologically confirmed diagnosis of R/R DLBCL. 2. Patientswho received at least one dose of tafasitamab in association with lenalidomide under the NPP (D.M. 7 Sep 2017), between April 2022 and December 2022. 3. Age ≥ 18 years at enrollment. 4. Signature of written informed consent (if applicable). Exclusion Criteria: 1\) R/R DLBCL patients who received tafasitamab in association with lenalidomide in a clinical trial context.
💊

What it tests

  • Not listed
📍

Where

11 sites
IRCCS Azienda Ospedaliero - Universitaria di Bologna
Bologna, Italy
AO Sant'Anna e San Sebastiano di Caserta
Caserta, Italy
A.R.N.A.S. Garibaldi
Catania, Italy
Azienda Ospedaliera Universitaria Arcispedale S. Anna
Ferrara, Italy
Azienda Ospedaliero Universitaria Careggi
Florence, Italy
Irccs Ospedale San Raffaele
Milan, Italy
Azienda Ospedaliero-Universitaria Maggiore della Carità
Novara, Italy
Azienda Ospedaliera Villa Sofia Cervello
Palermo, Italy

…and 3 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy